{{Rsnum
|rsid=1059823
|Gene=SLC11A1
|Chromosome=2
|position=218395121
|Orientation=plus
|GMAF=0.4559
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC11A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 39.8 | 46.9 | 13.3
| HCB | 46.0 | 43.1 | 10.9
| JPT | 54.9 | 39.8 | 5.3
| YRI | 1.4 | 14.3 | 84.4
| ASW | 10.5 | 22.8 | 66.7
| CHB | 46.0 | 43.1 | 10.9
| CHD | 49.5 | 44.0 | 6.4
| GIH | 44.6 | 49.5 | 5.9
| LWK | 1.8 | 26.4 | 71.8
| MEX | 44.8 | 34.5 | 20.7
| MKK | 3.2 | 35.5 | 61.3
| TSI | 35.3 | 52.0 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21524304
|Title=Evidence of association with type 1 diabetes in the SLC11A1 gene region
|OA=1
}}

{{PMID|18504650}} SLC11A1 polymorphisms are associated with the risk of chronic obstructive pulmonary disease in a Korean population.

{{PMID|19723394|OA=1
}} Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.

{{PMID|22008758}} SLC11A1 and VDR gene variants and susceptibility to tuberculosis and disease progression in East India.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}